MedPath

Triamcinolone

Generic Name
Triamcinolone
Brand Names
Allernaze, Aristocort, Aristocort R, Juulissa Pharmapak, Kenalog, Kourzeq, Marcaine, Nasacort, Oracort, Oralone, Pediaderm Ta, Triaderm, Trianex, Triderm, Triesence, Triloan Suik, Tritocin, Viaderm Kc, Xipere, Zilretta
Drug Type
Small Molecule
Chemical Formula
C21H27FO6
CAS Number
124-94-7
Unique Ingredient Identifier
1ZK20VI6TY
Background

Triamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis. Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain, or first line as a topical treatment of corticosteroid responsive dermatoses. Triamcinolone is more commonly seen in the forms triamcinolone hexacetonide, triamcinolone acetonide, and triamcinolone diacetate.

Triamcinolone was granted FDA approval on 3 December 1957. In October 2021, a suspension of triamcinolone acetonide was approved for suprachoroidal injection - the first suprachoroidal injection to receive FDA approval - for the treatment of patients with macular edema associated with uveitis.

Indication

肾上腺皮质激素类药。主要用于过敏性与自身免疫性炎症性疾病。由于本品潴钠作用较弱,故一般不用作肾上腺皮质功能减退的替代治疗。

Associated Conditions
Acne, Acne Vulgaris, Acute Gouty Arthritis, Allergic Contact Dermatitis, Allergic Rhinitis (AR), Allergic Skin Reaction, Alopecia Areata (AA), Ankylosing Spondylitis (AS), Aphthous Stomatitis, Asthma, Atopic Dermatitis, Autoimmune Hemolytic Anemia, Berylliosis, Bullous dermatitis herpetiformis, Chronic Eczema, Chronic Inflammatory Skin Diseases, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Contact Dermatitis, Crohn's Disease (CD), Dental Cavity, Dermatitis, Dermatomyositis (DM), Diaper Rash, Discoid Lupus Erythematosus (DLE), Edema of the cerebrum, Epicondylitis, Erythroderma, Fungal Infections, Fungal infectious disorders of the Beard, Fungal skin infection, Gingivitis, Haemorrhoids, Hemangiomas, Hypercalcemia, Inflammation of Mouth, Intertrigo, Itching of the Anus, Itching of the External Genitalia, Itching of the Foot, Itching of the genitals, Itching of the hand, Juvenile Idiopathic Arthritis (JIA), Keloids Scars, Leukemias, Lichen Planus (LP), Lichen simplex chronicus, Lymphoma, Macular Edema, Mycosis Fungoides (MF), Mycotic Eczema, Necrobiosis lipoidica diabeticorum, Neurodermatitis, Nummular Dermatitis, Ocular Inflammation, Ophthalmia, Sympathetic, Oral Erosive Lichen Planus, Otitis Externa, Pemphigus, Pericarditis, Polymyositis, Postherpetic Neuralgia, Primary adrenocortical insufficiency, Proteinuria, Psoriasis Vulgaris (Plaque Psoriasis), Psoriatic Arthritis, Psoriatic plaque, Pure Red Cell Aplasia, Purulent Wounds, Pyoderma caused by susceptible bacteria, Regional Enteritis, Rheumatoid Arthritis, Ringworm Folliculitis, Seborrheic Dermatitis, Seborrheic Dermatitis, Eczematous, Secondary Impetiginization, Secondary adrenocortical insufficiency, Secondary thrombocytopenia, Serum Sickness, Skin chapped, Stomatitis, Denture, Synovitis, Systemic Lupus Erythematosus, Temporal Arteritis, Tinea Corporis, Transfusion Reactions, Trichinosis, Tuberculosis (TB), Ulcerative Colitis, Urticaria, Uveitis, Wound Infections, Acute Bursitis, Acute Multiple sclerosis, Acute Rheumatic heart disease, unspecified, Acute Tenosynovitis, Corticosteroid-responsive dermatoses, Cutaneous candidiasis, Cystic tumour of the ganglia, Exfoliative erythroderma, Granuloma annulare lesions, Idiopathic eosinophilic pneumonias, Non-suppurative Thyroiditis, Oral infections, Oral lesions, Severe Erythema multiforme, Subacute Dermatitis, Eczematous, Symptomatic Sarcoidosis, Ulceration of the mouth, Ulcerative stomatitis

A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip

Phase 2
Not yet recruiting
Conditions
Osteoarthritis of Hip
Interventions
First Posted Date
2025-05-18
Last Posted Date
2025-05-18
Lead Sponsor
Pacira Pharmaceuticals, Inc
Target Recruit Count
32
Registration Number
NCT06977568
Locations
🇺🇸

Medical Pain Management Services PLLC, Albany, New York, United States

Additional Effect of Steroid on Hyaluronic Acid in Subdeltoid Bursitis

Phase 4
Not yet recruiting
Conditions
Subdeltoid Bursitis of the Shoulder
Interventions
First Posted Date
2025-04-20
Last Posted Date
2025-04-24
Lead Sponsor
Shin Kong Wu Ho-Su Memorial Hospital
Target Recruit Count
60
Registration Number
NCT06935877

Comparison of Intralesional Triamcinolone Versus Verapamil for Keloid Treatment

Phase 4
Not yet recruiting
Conditions
Keloid Scars
Interventions
First Posted Date
2025-03-27
Last Posted Date
2025-04-01
Lead Sponsor
Nishtar Medical University
Target Recruit Count
60
Registration Number
NCT06897969
Locations
🇵🇰

Nishtar Medical University & Hospital, Multan, Punjab, Pakistan

The Effectiveness of Intralesional Botulinum Toxin A and Triamcinolone Acetonide Injections in Keloid Treatment

Phase 2
Active, not recruiting
Conditions
Keloid Scars
Interventions
First Posted Date
2025-02-07
Last Posted Date
2025-02-07
Lead Sponsor
Universitas Padjadjaran
Target Recruit Count
20
Registration Number
NCT06814288
Locations
🇮🇩

Hasan Sadikin General Hospital, Bandung, Jawa Barat, Indonesia

Thyme Honey for Management of Oral Lichen Planus

Phase 1
Conditions
Oral Lichen Planus
Interventions
Dietary Supplement: thyme honey
First Posted Date
2025-02-06
Last Posted Date
2025-02-06
Lead Sponsor
British University In Egypt
Target Recruit Count
30
Registration Number
NCT06810752
Locations
🇪🇬

The British university in Egypt, Cairo, Egypt

Three Different Modalities for Treatment of Inflammatory Punctal Stenosis

Not Applicable
Completed
Conditions
Modalities
Treatment
Inflammatory Punctal Stenosis
Interventions
Procedure: Punctal dilation
Drug: Punctal dilation and topical medication
First Posted Date
2025-01-29
Last Posted Date
2025-01-29
Lead Sponsor
Tanta University
Target Recruit Count
60
Registration Number
NCT06798025
Locations
🇪🇬

Tanta University, Tanta, El-Gharbia, Egypt

Combined Corticosteroid Injections and Shockwave Therapy for Sacroiliac Joint Pain

Not Applicable
Not yet recruiting
Conditions
Sacroiliac Joint Dysfunction
Sacroiliac Joint Pain
Interventions
Device: extracorporeal shockwave
Device: extracorporeal shockwave(minimum intensity)
First Posted Date
2025-01-07
Last Posted Date
2025-01-09
Lead Sponsor
Tri-Service General Hospital
Target Recruit Count
44
Registration Number
NCT06761768

TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus

Phase 2
Recruiting
Conditions
Immunotherapy-related Pruritus
Interventions
First Posted Date
2024-12-27
Last Posted Date
2025-02-11
Lead Sponsor
University of California, San Diego
Target Recruit Count
28
Registration Number
NCT06748404
Locations
🇺🇸

University of California San Diego, La Jolla, California, United States

Effect of Superior Laryngeal Nerve Blocks on Patient Outcomes in Laryngeal Surgery

Phase 2
Not yet recruiting
Conditions
Vocal Cord Disease
Vocal Cord Polyp
Vocal Cord Cyst
Interventions
First Posted Date
2024-12-16
Last Posted Date
2025-01-20
Lead Sponsor
Rutgers, The State University of New Jersey
Target Recruit Count
28
Registration Number
NCT06734975
Locations
🇺🇸

Rutgers New Jersey Medical School, Newark, New Jersey, United States

INJECTABLE COLD ENERGY THERAPY FOR THE MANAGEMENT OF CHRONIC PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE

Not Applicable
Recruiting
Conditions
Osteoarthritis (OA) of the Knee
Interventions
Device: Neural Ice
First Posted Date
2024-11-21
Last Posted Date
2025-05-18
Lead Sponsor
Brixton Biosciences, Inc.
Target Recruit Count
263
Registration Number
NCT06700109
Locations
🇺🇸

Marin Health, Larkspur, California, United States

🇺🇸

Centers for Advanced Orthopedics, Washington, District of Columbia, United States

🇺🇸

The Orthopaedic Institute, Gainesville, Florida, United States

and more 12 locations
© Copyright 2025. All Rights Reserved by MedPath